Photo: Abe Garver Team Member

Abe Garver

Managing Director

Abe Garver, a FOCUS Managing Director, has over 20-years professional experience in M&A investment banking and management consulting. Over the course of his career, he has worked on sell-, buy- and capital-raise assignments for over 50 public, private and Inc. 500 fastest-growing companies.
Photo: Evans Love Team Member

Evans Love


Evans, an Associate on the Healthcare and Life Science team, joined FOCUS in January 2017. He has experience with the biotechnology, pharmaceutical development, and medical device industries, primarily concentrating on M&A projects in the clinical/contract research organization sector. His responsibilities include crafting and evaluating target lists for buy-side and sell-side engagements, financial modeling and analysis, researching and forecasting market trends, and assisting in business development.
Greg Hagfors Team Member

Greg Hagfors

Senior Advisor

Greg Hagfors, a FOCUS Senior Advisor, has been a senior level healthcare executive for over 25 years.  His interests are in strategy development and deployment, operational and financial performance enhancement, and leadership development.

Brett Griffith, President, Alpha Systems

“We are grateful for the expertise and professionalism that FOCUS brought to this transaction.  The sale of Alpha Systems to Databank would not have gone as seamlessly as it did had it not been for FOCUS.  They understand the needs of both buyers and sellers and ensured that the transaction went as smoothly as possible. …


Peggy Horn, President, SBC Systems

“SBC had been in business for over thirty years. When it came time for us to sell we interviewed a number of bankers. We selected FOCUS to represent SBC because we connected with their partners. Jonathan Wilfong and John Bradshaw provided invaluable advice as we worked through all of the issues. They helped us navigate …


Marco Calzavara, CEO, Bioline

"As a company founder who has built a bio-science business over 18 years, I selected FOCUS as our investment bank because of their biotechnology expertise and because of their understanding of the needs of an entrepreneur owner embarking on his first company sale. I was attracted to the fact that FOCUS offers a step-by-step process …


Billy Ching, Chair of the Private Equity Practice Group, Nelson Mullins

“It is never easy getting a deal to the closing table, especially one that takes two years to complete! Jonathan Wilfong, Regional Managing Partner at FOCUS LLC, was instrumental in the execution and closing of our recent complex healthcare M&A transaction. Mr. Wilfong’s tenacity and active management of the process, as well as a full …


Alan Rose, Co-Founder and Principal, Verify Solutions, LLC

“After five years in business providing “dependent eligibility” services to employers, it was time to merge our start-up operation into a larger organization to take advantage of operational synergies and growth opportunities. We interviewed a number of investment banking firms and Jonathan Wilfong stood out as the most experienced and professional. We later learned that …


Jeff Jarvis, CEO of Agentek

“FOCUS’ familiarity working with entrepreneurs and its ability to tap into a seasoned Senior Advisor network were essential in assisting Agentek on its journey from a great technology to a great business model that was attractive to numerous investors. In this transaction, the lead banker for FOCUS invited a Senior Advisor, who was the retired …


Robert Garces, Chairman of Alliance HealthCard

"The acquisition of Benefits Marketing Solutions was very important to the future of Alliance and was too important not to involve professionals who could ensure that the acquisition closed. From initial negotiation of the transaction terms to the deal closing, FOCUS professionals were there to assist us. They ensured that all of the necessary steps, …